OUR STORY

Enabling people with diabetes
to live a better life

OUR STORY

Enabling people with diabetes
to live a better life

Enabling people with diabetes to live a better life

Guidepost was established in 2012 to help improve the quality of life of people living with diabetes, a condition that affects more than 400 million people globally. Led by a team of medical doctors, scientists and AI specialists, we are committed to finding solutions to help as many people living with diabetes as possible.

There have been major advances in the treatment of diabetes, including new devices, technology and advice, but diabetes remains largely a self-care condition. To live a healthier life, and to reduce hospitalisations, diabetics need to pay close attention to their diet and lifestyle choices. This, more often than not, requires significant behaviour change, which is difficult to achieve without ongoing support.

We strive to lessen this burden, by offering sophisticated, personalized coaching, powered by AI. We have developed a platform that enables our more than 100 clinically trained professional coaches to proactively engage with people living with diabetes, providing unparalleled, personalized support.

Insurers and device makers have recognized the significant benefits of our offering and are providing our service to their clients. With Guidepost, they are able to help their clients to better manage their diabetes. This keeps them healthier and on treatment, resulting in better outcomes, which ultimately ensures that our partners’ businesses flourish too.

THE AI OPPORTUNITY

Putting our data to work

Every diabetes patient is unique and there are thousands of possible combinations of patient, barrier and necessary intervention to get the best results. To be able to scale to meet the massive demand for personalised coaching, we need expert clinical judgement at the touch of a button.

Over the last decade, there have been more than 1.2 million calls placed between coaches and clients. This has amassed a significant and unique data set. With the latest advances in machine learning, and specifically deep learning, we are finally at a point where we can support our coaches by helping automate complex judgement that managing diabetes requires. This presents an unparalleled opportunity to scale because our coaches now have the tools at their fingertips to work much faster with less training.

THE AI OPPORTUNITY

Putting our data to work

Every diabetes patient is unique and there are thousands of possible combinations of patient, barrier and necessary intervention to get the best results. To be able to scale to meet the massive demand for personalised coaching, we need expert clinical judgement at the touch of a button.

Over the last decade, there have been more than 1.2 million calls placed between coaches and clients. This has amassed a significant and unique data set. With the latest advances in machine learning, and specifically deep learning, we are finally at a point where we can support our coaches by helping automate complex judgement that managing diabetes requires. This presents an unparalleled opportunity to scale because our coaches now have the tools at their fingertips to work much faster with less training.

Our team

Graham Rowe

Ceo and co-founder

Professor David Segal

Chief medical officer and Co-founder

Jacob Flanders

Product Lead

Greg Van Berkel

Chief technology Officer

Renier van Rooyen

AI Lead

Tracy Hesslewood

Solutions & Quality Executive

Alexandra Menego

Operations Executive

Our team

Graham Rowe

Ceo and co-founder

Jacob Flanders

Product Lead

Renier van Rooyen

AI Lead

Alexandra Menego

Operations Executive

Professor David Segal

Chief medical officer and Co-founder

Greg Van Berkel

Chief technology Officer

Tracy Hesslewood

Solutions & Quality Executive

Our team

Graham Rowe

Ceo and co-founder

Professor David Segal

Chief medical officer and Co-founder

Jacob Flanders

Product Lead

Greg Van Berkel

Chief technology Officer

Renier van Rooyen

AI Lead

Tracy Hesslewood

Solutions & Quality Executive

Alexandra Menego

Operations Executive

Our board

Graham Rowe

Ceo and co-founder

Professor David Segal

Chief medical officer and Co-founder

Herschel Mayers

Non-Exec Chairman

Marc Herson

Observer

Dominique Collett

Non-Exec

John Seymour

Non-Exec

Richard Johnson

Non-Exec

Our board

Graham Rowe

Ceo and co-founder

Herschel Mayers

Non-Exec Chairman

Dominique Collett

Non-Exec

Richard Johnson

Non-Exec

Professor David Segal

Chief medical officer and Co-founder

Marc Herson

Observer

John Seymour

Non-Exec

Our board

Graham Rowe

Ceo and co-founder

Professor David Segal

Chief medical officer and Co-founder

Herschel Mayers

Non-Exec Chairman

Marc Herson

Observer

Dominique Collett

Non-Exec

John Seymour

Non-Exec

Richard Johnson

Non-Exec